165 related articles for article (PubMed ID: 18581211)
1. A novel nanocapsule delivery system to overcome intestinal degradation and drug transport limited absorption of P-glycoprotein substrate drugs.
Nassar T; Rom A; Nyska A; Benita S
Pharm Res; 2008 Sep; 25(9):2019-29. PubMed ID: 18581211
[TBL] [Abstract][Full Text] [Related]
2. Novel double coated nanocapsules for intestinal delivery and enhanced oral bioavailability of tacrolimus, a P-gp substrate drug.
Nassar T; Rom A; Nyska A; Benita S
J Control Release; 2009 Jan; 133(1):77-84. PubMed ID: 18822327
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus is a class II low-solubility high-permeability drug: the effect of P-glycoprotein efflux on regional permeability of tacrolimus in rats.
Tamura S; Ohike A; Ibuki R; Amidon GL; Yamashita S
J Pharm Sci; 2002 Mar; 91(3):719-29. PubMed ID: 11920757
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Role of P-glycoprotein (P-gp)-Mediated Efflux in the Intestinal Absorption of Common Substrates with Elacridar, a P-gp Inhibitor, in Rats.
Suzuki K; Taniyama K; Aoyama T; Watanabe Y
Eur J Drug Metab Pharmacokinet; 2020 Jun; 45(3):385-392. PubMed ID: 32078103
[TBL] [Abstract][Full Text] [Related]
5. Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of p-glycoprotein.
Dahan A; Amidon GL
Pharm Res; 2009 Apr; 26(4):883-92. PubMed ID: 19048359
[TBL] [Abstract][Full Text] [Related]
6. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
[TBL] [Abstract][Full Text] [Related]
7. Enhanced intestinal absorption of daidzein by borneol/menthol eutectic mixture and microemulsion.
Shen Q; Li X; Li W; Zhao X
AAPS PharmSciTech; 2011 Dec; 12(4):1044-9. PubMed ID: 21842308
[TBL] [Abstract][Full Text] [Related]
8. The role of turmerones on curcumin transportation and P-glycoprotein activities in intestinal Caco-2 cells.
Yue GG; Cheng SW; Yu H; Xu ZS; Lee JK; Hon PM; Lee MY; Kennelly EJ; Deng G; Yeung SK; Cassileth BR; Fung KP; Leung PC; Lau CB
J Med Food; 2012 Mar; 15(3):242-52. PubMed ID: 22181075
[TBL] [Abstract][Full Text] [Related]
9. The impact of P-glycoprotein efflux on enterocyte residence time and enterocyte-based metabolism of verapamil.
Johnson BM; Charman WN; Porter CJ
J Pharm Pharmacol; 2001 Dec; 53(12):1611-9. PubMed ID: 11804391
[TBL] [Abstract][Full Text] [Related]
10. Short-chain fatty acids oppositely altered expressions and functions of intestinal cytochrome P4503A and P-glycoprotein and affected pharmacokinetics of verapamil following oral administration to rats.
Zhang J; Xie Q; Kong W; Wang Z; Wang S; Zhao K; Chen Y; Liu X; Liu L
J Pharm Pharmacol; 2020 Mar; 72(3):448-460. PubMed ID: 31863502
[TBL] [Abstract][Full Text] [Related]
11. High-dose etoposide formulations do not saturate intestinal P-glycoprotein: Development, stability, and pharmacokinetics in Sprague-Dawley rats.
Al-Ali AAA; Sandra L; Versweyveld D; Pijpers I; Dillen L; Vermeulen A; Snoeys J; Holm R; Nielsen CU
Int J Pharm; 2020 Jun; 583():119399. PubMed ID: 32376439
[TBL] [Abstract][Full Text] [Related]
12. Induction of human P-glycoprotein in Caco-2 cells: development of a highly sensitive assay system for P-glycoprotein-mediated drug transport.
Shirasaka Y; Kawasaki M; Sakane T; Omatsu H; Moriya Y; Nakamura T; Sakaeda T; Okumura K; Langguth P; Yamashita S
Drug Metab Pharmacokinet; 2006 Oct; 21(5):414-23. PubMed ID: 17072095
[TBL] [Abstract][Full Text] [Related]
13. The effects of PLGA microparticles on intestinal absorption of p-glycoprotein substrate using the everted rat intestinal sac model.
Derakhshandeh K; Hosseinalizadeh A; Nikmohammadi M
Arch Pharm Res; 2011 Nov; 34(11):1989-97. PubMed ID: 22139699
[TBL] [Abstract][Full Text] [Related]
14. Regional difference in P-glycoprotein function in rat intestine.
Iida A; Tomita M; Hayashi M
Drug Metab Pharmacokinet; 2005 Apr; 20(2):100-6. PubMed ID: 15855720
[TBL] [Abstract][Full Text] [Related]
15. Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery.
Benet LZ; Izumi T; Zhang Y; Silverman JA; Wacher VJ
J Control Release; 1999 Nov; 62(1-2):25-31. PubMed ID: 10518631
[TBL] [Abstract][Full Text] [Related]
16. Rational design of polyarginine nanocapsules intended to help peptides overcoming intestinal barriers.
Niu Z; Tedesco E; Benetti F; Mabondzo A; Montagner IM; Marigo I; Gonzalez-Touceda D; Tovar S; DiƩguez C; Santander-Ortega MJ; Alonso MJ
J Control Release; 2017 Oct; 263():4-17. PubMed ID: 28235590
[TBL] [Abstract][Full Text] [Related]
17. Application of compartmental modeling to an examination of in vitro intestinal permeability data: assessing the impact of tissue uptake, P-glycoprotein, and CYP3A.
Johnson BM; Charman WN; Porter CJ
Drug Metab Dispos; 2003 Sep; 31(9):1151-60. PubMed ID: 12920171
[TBL] [Abstract][Full Text] [Related]
18. A study of intestinal absorption of bicyclol in rats: active efflux transport and metabolism as causes of its poor bioavailability.
Tan W; Chen H; Zhao J; Hu J; Li Y
J Pharm Pharm Sci; 2008; 11(3):97-105. PubMed ID: 18801310
[TBL] [Abstract][Full Text] [Related]
19. Interplay between CYP3A-mediated metabolism and polarized efflux of terfenadine and its metabolites in intestinal epithelial Caco-2 (TC7) cell monolayers.
Raeissi SD; Hidalgo IJ; Segura-Aguilar J; Artursson P
Pharm Res; 1999 May; 16(5):625-32. PubMed ID: 10350002
[TBL] [Abstract][Full Text] [Related]
20. A kinetic evaluation of the absorption, efflux, and metabolism of verapamil in the autoperfused rat jejunum.
Johnson BM; Chen W; Borchardt RT; Charman WN; Porter CJ
J Pharmacol Exp Ther; 2003 Apr; 305(1):151-8. PubMed ID: 12649363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]